JPS5136273B2 - - Google Patents
Info
- Publication number
- JPS5136273B2 JPS5136273B2 JP49060325A JP6032574A JPS5136273B2 JP S5136273 B2 JPS5136273 B2 JP S5136273B2 JP 49060325 A JP49060325 A JP 49060325A JP 6032574 A JP6032574 A JP 6032574A JP S5136273 B2 JPS5136273 B2 JP S5136273B2
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7319734A FR2231374B1 (en:Method) | 1973-05-30 | 1973-05-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5030863A JPS5030863A (en:Method) | 1975-03-27 |
| JPS5136273B2 true JPS5136273B2 (en:Method) | 1976-10-07 |
Family
ID=9120281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP49060325A Expired JPS5136273B2 (en:Method) | 1973-05-30 | 1974-05-30 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4014909A (en:Method) |
| JP (1) | JPS5136273B2 (en:Method) |
| BE (1) | BE815590A (en:Method) |
| CA (1) | CA1041083A (en:Method) |
| FR (1) | FR2231374B1 (en:Method) |
| GB (1) | GB1475795A (en:Method) |
| NL (1) | NL163221C (en:Method) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6175974U (en:Method) * | 1984-10-24 | 1986-05-22 |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6144070Y2 (en:Method) * | 1978-05-15 | 1986-12-12 | ||
| FR2442856A1 (fr) * | 1978-12-01 | 1980-06-27 | Sipsy | Procede de preparation de steroides |
| US4262940A (en) * | 1978-12-15 | 1981-04-21 | The Johnson Corporation | Internally compensated self-aligning rotary joint |
| FR2529894B2 (fr) * | 1981-07-30 | 1986-07-25 | Jouveinal | Steroides esterifies en la position 17 et thio-esterifies en la position 21 et leur application comme medicament |
| FR2510582B1 (fr) * | 1981-07-30 | 1986-05-30 | Sipsy | Steroides esterifies en la position 17 et thio-esterifies en la position 21, leur procede de preparation et leur application comme medicament |
| FR2551069B1 (fr) * | 1983-08-26 | 1986-07-25 | Jouveinal Sa | 17-oxo-21-thioesters d'hydrocortisone, leur preparation et leurs applications comme medicament |
| US4861765A (en) * | 1985-06-26 | 1989-08-29 | Jouveinal | 21-alkyl-, cycloalkyl- or aryl-substituted thio steroids and pharmaceutical compositions containing them |
| US5116829A (en) * | 1990-04-23 | 1992-05-26 | Kao Corporation | Steroid compounds |
| US5439901A (en) * | 1993-07-23 | 1995-08-08 | The Procter & Gamble Company | Cyproterone thiopivalate |
| US5420120A (en) * | 1993-12-17 | 1995-05-30 | Alcon Laboratories, Inc. | Anti-inflammatory glucocorticoid compounds for topical ophthalmic use |
| US5602094A (en) * | 1994-03-29 | 1997-02-11 | Goddard; David | Treatment of tumors |
| IES68868B2 (en) * | 1996-03-20 | 1996-07-24 | Losbanos Ltd | Manufacture of steroids |
| EP1238285A1 (en) * | 1999-11-30 | 2002-09-11 | Akzo Nobel N.V. | Steroid compounds for steroid receptor binding assays |
| US7825147B2 (en) * | 2003-08-29 | 2010-11-02 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-IV |
| US20070259874A1 (en) * | 2003-11-26 | 2007-11-08 | Palle Venkata P | Phosphodiesterase Inhibitors |
| US20080009535A1 (en) * | 2004-08-30 | 2008-01-10 | Sarala Balachandran | Inhibitors of phosphodiesterase type-IV |
| US7915286B2 (en) | 2005-09-16 | 2011-03-29 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| CA2626628A1 (en) * | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type iv inhibitors |
| WO2007045979A1 (en) | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of muscarinic receptor antagonists |
| MX2009003100A (es) * | 2006-09-22 | 2009-05-11 | Ranbaxy Lab Ltd | Inhibidores de fosfodiesterasa tipo iv. |
| US20100029728A1 (en) * | 2006-09-22 | 2010-02-04 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
| US20080207659A1 (en) * | 2007-02-15 | 2008-08-28 | Asit Kumar Chakraborti | Inhibitors of phosphodiesterase type 4 |
| PT2124944E (pt) * | 2007-03-14 | 2012-05-17 | Ranbaxy Lab Ltd | Derivados de pirazolo[3,4-b]piridina como inibidores de fosfodiesterase |
| US20110130403A1 (en) * | 2007-03-14 | 2011-06-02 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
| CL2008003802A1 (es) * | 2007-12-21 | 2010-02-19 | Schering Corp | Compuestos derivados de tioeteres c-21, agonistas del receptor de glucocorticoide; composicion farmaceutica; y uso para el tratamiento o profilaxis de una enfermedad o afeccion inmune, autoinmune o inflamatoria, tales como artritis reumatoide y esclerosis multiple. |
| EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
| EP3153502B1 (fr) * | 2013-09-25 | 2018-12-19 | H4 Pharma | Procédé de synthèse d'un sel minéral de l'acide pivalique en tant que produit intermédiaire |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2814632A (en) * | 1957-02-21 | 1957-11-26 | Schering Corp | Steroid compounds and methods for their manufacture |
| FR1187M (fr) * | 1961-03-17 | 1962-03-19 | Roussel Uclaf | Nouveau médicament notamment pour le traitement des manifestations inflammatoires d'origine rhumatismale arthritique ou infectieuse. |
| DE2044831A1 (en:Method) * | 1969-09-18 | 1971-03-25 | ||
| CH566349A5 (en:Method) * | 1969-12-24 | 1975-09-15 | Ciba Geigy Ag | |
| US3803133A (en) * | 1972-12-15 | 1974-04-09 | Squibb & Sons Inc | 21-sulfinyl steroids |
-
1973
- 1973-05-30 FR FR7319734A patent/FR2231374B1/fr not_active Expired
-
1974
- 1974-05-28 BE BE1005987A patent/BE815590A/xx not_active IP Right Cessation
- 1974-05-28 US US05/473,388 patent/US4014909A/en not_active Expired - Lifetime
- 1974-05-29 NL NL7407176.A patent/NL163221C/xx not_active IP Right Cessation
- 1974-05-29 CA CA201,149A patent/CA1041083A/fr not_active Expired
- 1974-05-30 JP JP49060325A patent/JPS5136273B2/ja not_active Expired
- 1974-05-30 GB GB2399274A patent/GB1475795A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6175974U (en:Method) * | 1984-10-24 | 1986-05-22 |
Also Published As
| Publication number | Publication date |
|---|---|
| BE815590A (fr) | 1974-09-16 |
| DE2357778B2 (de) | 1977-02-17 |
| DE2357778A1 (de) | 1974-12-19 |
| NL163221C (nl) | 1980-08-15 |
| JPS5030863A (en:Method) | 1975-03-27 |
| FR2231374B1 (en:Method) | 1976-10-22 |
| NL163221B (nl) | 1980-03-17 |
| FR2231374A1 (en:Method) | 1974-12-27 |
| NL7407176A (en:Method) | 1974-12-03 |
| US4014909A (en) | 1977-03-29 |
| CA1041083A (fr) | 1978-10-24 |
| GB1475795A (en) | 1977-06-10 |